HSCT Seen as Superior to Current Therapies for Severe, Progressive Sclerosis
Autologous hematopoietic stem cell transplantation (HSCT), evaluated in 18 people with rapidly progressing systemic sclerosis, found the experimental therapy superior to standard treatments for the disease for this patient population. The retrospective report detailing these findings, “Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive…